Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Heparin for AVF Maturation in Hemodialysis Patients
NCT01382888Phase 2Terminated
- Sponsor
- Cyathus Exquirere PharmaforschungsGmbH
- Start
- Jul 2011
- Primary completion
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in arteriovenous fistula (AVF) comparing Heparin Spray with Placebo Spray (2 arms). Primary endpoint: Suitability of newly constructed primary arteriovenous fistulas at 7 weeks. Started Jul 2011; status: terminated.
02
Drugs
heparin
03
Conditions
arteriovenous fistula (AVF)
Beyond the preview
Go deeper on NCT01382888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01382888.